MENUNews and Events
Recent Releases
04/11/2024 - 4:15pm
Zhou gets $2.9M to develop a system to predict outcomes in multiple myeloma
By combining data from MRI scans and clinical tests, University of Michigan Rogel Cancer Center researcher Chuan Zhou, Ph.D., will develop a decision support tool to tailor treatment for individual patients with multiple myeloma. It’s a cancer that’s considered incurable, with survival ranging from less than a year to more than a decade, depending on the extent and aggressiveness of the tumors.
04/10/2024 - 3:45pm
AACR 2024: Rogel Recap of the 2024 AACR Annual Meeting
Highlights from Rogel's presence at the 2024 AACR Annual Meeting
04/10/2024 - 2:00pm
AACR 2024: NextGen Star Abhijit Parolia presents on new protein that drives prostate cancer progression
Abhijit Parolia, M.S., Ph.D., assistant professor of pathology and urology at the University of Michigan Health Rogel Cancer Center, was named at NextGen Star by the American Association of Cancer Research.
04/09/2024 - 5:15pm
AACR 2024: Ljungman speaks on “KLIPP,” a new technique targeting cancer with CRISPR
Mats Ljungman, Ph.D., Rogel researcher and professor of radiation oncology, shared research on KLIPP, a new technique in precision medicine using CRISPR to target weak spots in cancer cells, at the American Association of Cancer Research's Annual Meeting.
04/07/2024 - 7:45pm
AACR 2024: Chinnaiyan presents on possible therapies to target oncogenic transcription factors
Arul Chinnaiyan, M.D., Ph.D., was one of several Rogel researchers to present at the American Association for Cancer Research 2024 Annual Meeting.
Publications
